As previously reported, BofA downgraded Check Point (CHKP) to Neutral from Buy with a price target of $195, down from $205. While the “focal point of the quarter” was the weak billings growth of 5.8% year-over-year, the firm is less worried about billings that it believes will largely recover next quarter and more focused on the low growth trajectory despite new products and general go-to-market challenges, the analyst tells investors. The Street is generally looking for visibility towards double digit growth and the firm’s analysis “suggests it would not be feasible in 2025,” the analyst says in a post-earnings note.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHKP: